Turkish Journal of Medical Sciences
Volume 44

Number 4

Article 2

1-1-2014

Comparison of intraarticular bupivacaine and levobupivacaine
injection in rat synovial inflammation
BEKİR SUAT KÜRKÇÜOĞLU
MELAHAT DÖNMEZ
SEHER ALTINEL
SEDA BANU AKINCI
FATMA SARICAOĞLU

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KÜRKÇÜOĞLU, BEKİR SUAT; DÖNMEZ, MELAHAT; ALTINEL, SEHER; AKINCI, SEDA BANU; SARICAOĞLU,
FATMA; and AYPAR, ÜLKÜ (2014) "Comparison of intraarticular bupivacaine and levobupivacaine injection
in rat synovial inflammation," Turkish Journal of Medical Sciences: Vol. 44: No. 4, Article 2. https://doi.org/
10.3906/sag-1302-32
Available at: https://journals.tubitak.gov.tr/medical/vol44/iss4/2

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Comparison of intraarticular bupivacaine and levobupivacaine injection in rat
synovial inflammation
Authors
BEKİR SUAT KÜRKÇÜOĞLU, MELAHAT DÖNMEZ, SEHER ALTINEL, SEDA BANU AKINCI, FATMA
SARICAOĞLU, and ÜLKÜ AYPAR

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol44/iss4/2

Turkish Journal of Medical Sciences

Turk J Med Sci
(2014) 44: 540-545
© TÜBİTAK
doi:10.3906/sag-1302-32

http://journals.tubitak.gov.tr/medical/

Research Article

Comparison of intraarticular bupivacaine and levobupivacaine
injection in rat synovial inflammation
1,

2

3

4

Bekir Suat KÜRKÇÜOĞLU *, Melehat DÖNMEZ , Seher ALTINEL , Seda Banu AKINCI ,
4
4
Fatma SARICAOĞLU , Ülkü AYPAR
1
Department of Anesthesia and Reanimation, Atatürk Education and Research Hospital, Ankara, Turkey
2
Department of Pathology, Ankara Education and Research Hospital, Ankara, Turkey
3
Department of Anesthesia and Reanimation, Keçiören Education and Research Hospital, Ankara, Turkey
4
Department of Anesthesia and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Received: 09.02.2013

Accepted: 23.09.2013

Published Online: 27.05.2014

Printed: 26.06.2014

Background/aim: Both bupivacaine and levobupivacaine are local anesthetics with strong analgesic efficacy that can be used
intraarticularly. The aim of this study was to compare the effects of intraarticular bupivacaine and levobupivacaine injection on
inflammation in articular cartilage and the synovium of the rat knee joint.
Materials and methods: Twenty Sprague-Dawley rats were injected in the right knee joint with 0.2 mL of bupivacaine, while 0.2 mL
of levobupivacaine was injected into the left knee joint. Groups of 5 were sacrificed on days 1, 7, 14, and 21 after bupivacaine and
levobupivacaine administration and knee joints were examined for subintimal fibrosis, synovial hyperplasia, chronic inflammation,
neutrophil infiltration, edema, and synovial and periarticular congestion by microscopy. Alterations in the articular cartilage structure
were evaluated using Mankin scoring.
Results: We found that both drugs have similar effects on synovial and articular cartilage resulting in mild to moderate congestion,
edema, neutrophil infiltration, chronic inflammation, and synovial hyperplasia, which diminished gradually. However, increases in
fibrosis were also seen to varying degrees. Thus, the use of these drugs intraarticularly can be recommended.
Conclusion: Careful usage of bupivacaine and levobupivacaine is recommended in intraarticular applications since they cause
inflammation shortly after injection and fibrosis at later time points.
Key words: Bupivacaine, levobupivacaine, intraarticular, rat, articular cartilage, histopathological changes

1. Introduction
Arthroscopic surgical interventions for diagnosis and
treatment are prevalent in surgical practices. Local
anesthetics are used alone or administered as an
intraarticular treatment during arthroscopic surgical
interventions to provide postoperative pain control
(1,2). Bupivacaine amide is a local anesthetic (LA) with
long-lasting efficacy (3) lasting approximately 5 h, and
its duration of efficacy can be extended to 10 h with the
addition of adrenaline (4). Levobupivacaine is a longlasting LA with an S(-) isomer of bupivacaine and an
amide structure. As with all LA agents, levobupivacaine
functions by altering voltage-sensitive channels in neural
membranes (3). Understanding the histopathological
effects of intraarticularly injected LAs is critical as they
may alter the joint cartilage and the synovium (5).
* Correspondence: bekirsuat@gmail.com
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The purpose of our study is to compare the
histopathological
effects
of
bupivacaine
and
levobupivacaine on joint cartilage and the synovium after
intraarticular injection into rat knee joints.
2. Materials and methods
This study was carried out in cooperation with the
Hacettepe University Faculty of Medicine Anesthesiology
and Reanimation Department, the Hacettepe University
Faculty of Medicine Experimental Animals Laboratory,
and the Ankara Education and Research Hospital
Pathology Clinic after the approval of the Hacettepe
University Experimental Animals Ethics Committee. All
surgical operations were completed in accordance with the
Declaration of Helsinki on animal rights.
We used 20 male Sprague-Dawley rats weighing
270–320 g, housed together in the Hacettepe University
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Experimental Animals Laboratory. During the experiment,
5 rats were kept per cage, were fed with standard laboratory
food, and had unrestricted access to water and food.
The rats were anesthetized with 0.4 mg kg–1 midazolam
injected intraperitoneally. Under aseptic conditions, 0.2
mL of bupivacaine (5 mg mL–1) was injected in the right
knee joint and 0.2 mL of levobupivacaine (5 mg mL–1) in
the left knee joint of each rat. The rats were sacrificed with
30 mg kg–1 (a lethal dose) intraperitoneal ketamine (50 mg
mL–1) on days 1, 7, 14, and 21 after intraarticular injection.
The area was then cleaned and arthrotomy was performed
on both knees of rats with a medial parapatellar incision.
After the distal femur anterior surface was opened by
moving the patella laterally, the incision was extended
distally to the tibial anterior surface. We separated all soft
tissues from the femur and tibia and the intact knee joints
were removed. After macroscopically examining whether
there was hematoma, the right (R) and left (L) knees from
each group (group 1: day 1, group 2: day 7, group 3: day
14, and group 4: day 21) were labeled and prepared for
histology.
Tissue samples were fixed at room temperature in
10% formalin for 2 weeks and then decalcified with De
Castro solution for 4 weeks. During the decalcification
process, tissues were checked every 3 days and the
De Castro solution was replaced. After tissues were
decalcified and fixed in 10% formalin buffer, they were
monitored by light microscopy. Serial sections of 5 µm
were cut from tissue samples and stained using standard
protocols for hematoxylin and eosin and Masson’s
trichrome staining. Stained sections were examined and
photographed by 2 histologists using a Leica DM 6000B

(Wetzlar, Germany) microscope connected to a DC490
digital camera (Leica).
The knee joint, peripheral areas, and synovium were
examined for inflammation. Inflammatory changes were
evaluated according to a 4-parameter scoring system
(Table 1). Changes that occurred in the joint cartilage
structure were evaluated using a modified Mankin score
with 4 different parameters (Table 2).
2.1. Statistical analysis
Statistical analysis was completed using SPSS 12.0 (SPSS
Inc., Chicago, IL, United States). Mann–Whitney U
tests were used to compare the severity of inflammatory
changes between 2 groups. Results were presented as
medians (min–max). A chi-square test (Pearson chisquare or Fisher exact chi-square test) was used in group
comparisons for categorical changes (inflammation
degree). Results were considered statistically significant at
P < 0.05.
3. Results
No macroscopic hematomas were observed in any of the
40 knee joints examined. No severe congestion or edema
was observed in either group (R or L); however, slight
congestion and edema was observed in the rat knees on
day 7. When any 2 groups were internally examined, the
difference between them was not statistically significant
(day 1: P = 0.262; day 7: P = 1; day 14: P = 0.50; day 21: P
= 0.262).
Rat knee joints were examined for neutrophil
infiltration and a slight level infiltration was seen on day 1
(P = 0.262). No neutrophil infiltration was detected in any
of the knees on the subsequent days.

Table 1. Grading system for histopathological inflammatory changes in rats injected
with bupivacaine and levobupivacaine.

Histological feature

Score
0

1

2

3

Congestion, edema

Normal

Mild

Moderate

Severe

Neutrophil infiltration

Normal

Mild

Moderate

Severe

Chronic inflammation

Normal

Mild

Moderate

Severe

Synovial hyperplasia*

0

1

2

3

Subintimal fibrosis**

10%↓

10-30%

30-50%

50%↑

*: Synovial hyperplasia: Scored according to ranking of synovitis. 0 points: Single layer
of synovitis, 1 point: 2 layers of synovitis, 2 points: 3 layers of synovitis, 3 points: 4 layers
of synovitis.
**: Subintimal fibrosis: Percentage of fibrotic tissue in the loose joint tissue during
synovitis in Masson’s trichrome-stained sections.
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Table 2. Modified Mankin histological scoring system.
Histologic
feature

0

1

2

Cartilage
structure

Normal

Surface
irregularities

Pannus and surface Clefts to
irregularities
transitional zone

Cartilage cells

Normal

Pyknosis, lipid
degeneration,
hypercellularity

Clusters

Hypocellularity

Staining with
Masson’s
trichrome

Normal

Slight reduction

Moderate
reduction

Severe
reduction

Tidemark
integrity

Intact

Destroyed

3

When joints were examined for chronic inflammation,
severe levels of chronic inflammation were observed in
only 1 rat, which had been given levobupivacaine and was
sacrificed on day 7, while low or moderate levels of chronic
inflammation were observed in all groups. Differences in
chronic inflammation were not significant between the
groups (Table 3).
Severe synovial hyperplasia was not observed in the
joints. Low to moderate hyperplasia was observed on days
1, 7, and 14 and slight hyperplasia was observed in both
groups on day 21. When both groups were compared, no
statistical significance was detected.
While subintimal fibrosis percentages were below 50%
in the knees, it was noted that recovery resulted in fibrosis
at various levels for both groups on days 1 (P = 0.262), 7 (P
= 0.668), 14 (P = 0.50), and 21 (P = 0.577).
Table 3. Chronic inflammation scores for each group.
Chronic
inflammation

0

1

2

3

Day 1 (group R)

0

4

1

0

Day 1 (group L)

0

4

1

0

Day 7 (group R)

0

3

2

0

Day 7 (group L)

0

1

3

1

Day 14 (group R)

0

4

1

0

Day 14 (group L)

0

3

2

0

Day 21 (group R)

0

4

1

0

Day 21 (group L)

0

5

0

0
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P
0.778

0.160

0.500

0.500

4

5

6

Clefts to
radial zone

Clefts to
calcified zone

Complete
disorganization

No staining

No statistical difference was found between the 2
groups when histological features were subjected to
modified Mankin scoring, as the Mankin score was below
4 in all rat knees (day 1: P = 0.180; day 7: P = 0.095; day 14:
P = 0.453; day 21: P = 0.738) (Figures 1a–1f).
4. Discussion
This study has determined that bupivacaine and
levobupivacaine have similar effects on rat knee joints.
Congestion, edema, neutrophil infiltration, chronic
inflammation, and synovial hyperplasia were at low-tomoderate levels and decreased on day 21. Recovery of
the joint was associated with fibrosis at various levels,
proving that intraarticular usage of bupivacaine and
levobupivacaine should be considered carefully.
Intraarticular treatment is widely used in arthroscopic
procedures to provide preemptive and postoperative
analgesia. The most commonly used medications are
bupivacaine, NSAIDs, and morphine, whose intraarticular
use has been well studied (2,6–11). However, few
studies have examined the histopathological effects of
intraarticular treatment in the joints (4,12,13).
In a study by Ozyuvaci et al. (14), tenoxicam was
injected intraarticularly to the knee joints of 50 rats, which
were then separated into groups of 10, and pathological
changes in the joints were observed on days 2, 7, 14, and
21. No pathology was observed in the control group on
days 1 and 2, while tissue loss and edema were observed
in all rats treated with tenoxicam. No pathological changes
were observed in either group on days 7, 14, and 21. In
the bupivacaine and levobupivacaine groups, we observed
statistically significant inflammation on day 1, while firstand second-degree inflammation was observed in a subset
of the rats at the other time points. However, no significant
difference was found when 2 groups were compared.
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a

b

c

d

e

f

Figure 1. a) Representative day 1 tissues demonstrating congestion and edema observed in synovium of R and L group rats; b)
representative day 1 tissues showing neutrophil infiltration and synovial hyperplasia observed in synovium in R and L group rats; c)
representative day 7 tissues showing low levels of chronic inflammation with single layer of synovitis in R and L group rats; d) image of
joint cartilage demonstrating clustering of chondrocytes and surface irregularity (on the left); e) representative day 7 tissues from R and
L group rats stained with Masson’s trichrome, demonstrating 30%–50% subintimal fibrosis; f) representative day 14 tissues from R and
L groups showing low levels of chronic inflammation, single layer synovitis, and clusters of chondrocytes.

The effects of NSAIDs in intraarticular usage are
most commonly studied. Studies by Fjuii et al. (12) on
chondrocyte cultures and studies by David et al. (15) on
human osteoarthritic cartilage in vitro showed that different
NSAIDs had diverse effects on cartilage metabolism and
proteoglycan synthesis. According to a study by Romsin et
al. (16), NSAIDs, when injected locally, are able to inhibit
proteoglycan synthesis and when injected systemically
prevent chondrocyte metabolism.
In a study by Chu et al. (17), fresh bovine chondrocytes
were treated with 0.5% bupivacaine or 0.9% saline
and then examined by flow cytometry for apoptosis.
Apoptosis was found in 20% of chondrocytes exposed to
saline, while this rate was over 99% in the chondrocytes
exposed to bupivacaine. Furthermore, it was shown that
in vitro bupivacaine treatment was toxic to cartilage
and chondrocytes and that intraarticular treatment with
bupivacaine also had a similar effect on joint cartilage and
chondrocytes.

In another study, the histopathological effects of
intraarticular lornoxicam injections were examined in the
knee joints of 25 rats on days 1, 2, 7, 14, and 21. On day
1, congestion, edema, and low neutrophil infiltration were
detected in only 1 of the knees treated with lornoxicam,
while no changes were found at other time points. Thus,
intraarticular lornoxicam had no significant inflammatory
effect on joints.
In a study carried out by Dogan et al. on rabbit knees
(19), saline, bupivacaine, or neostigmine were injected
intraarticularly and knee joints were histopathologically
examined 1, 2, and 10 days after injection. Although
findings were more severe with neostigmine treatment,
bupivacaine injection also caused more increased
inflammation, inflammatory cell infiltration, synovial
hyperplasia, and hypertrophy than saline in joint cartilage
and the synovium (19).
Gomoll et al. (20) developed an empirical model
using 30 rabbits divided into 3 groups treated with saline
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as a continuous infusion, bupivacaine as a continuous
infusion, or bupivacaine and epinephrine as a continuous
infusion into shoulder joints for 48 h. When osteochondral
and synovial samples from the glenohumeral joint were
examined by measuring metabolic sulfate acquisition after
1 week, sulfate was decreased by 50% and 56%, respectively,
in bupivacaine and bupivacaine and epinephrine
continuous-infusion groups compared with the saline
continuous-infusion group. When cell survival rates were
measured, the decrease was 32% and 20%, respectively.
Significantly lower inflammation scores were noted during
histological analysis in the bupivacaine and epinephrine (P
= 0.004) and bupivacaine (P = 0.02) groups.
In a study by Erden et al., histopathological
examination was done on days 1, 7, 14, and 21 after saline
or levobupivacaine was injected into the rat knee joint. No
inflammatory changes were observed in the saline group
while minimal inflammation was observed in 4 rats from
the levobupivacaine group (21).

Anakwenze et al. (22) reported 2 cases where young
patients had glenohumeral chondrolysis, which developed
after treatment with bupivacaine intraarticular pain
pumps. Studies on the effects of bupivacaine in the joint
have shown that the consequences of intraarticular
usage differ depending on the model used. Results from
these studies indicate that multiple treatments with
intraarticular bupivacaine or continuous infusion of
bupivacaine damages the chondrocytes and the synovium.
In this study, we observed that a single dose of
bupivacaine or levobupivacaine resulted in similar effects
on joint cartilage and the synovium. Usage of these
medications is recommended since congestion, chronic
inflammation and synovitis, and hyperplasia were at lowto-moderate levels and gradually decreased. However,
the fibrosis that develops during recovery indicates that
intraarticular injection of bupivacaine or levobupivacaine
should be used cautiously. On the other hand, seeing
chronic inflammation in only 1 rat that was sacrificed
on day 7 is remarkable. There may be different results in
studies implemented with greater numbers of rats.
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